BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years.

British Journal of Cancer
L RobertsonBCSC (UK)

Abstract

Triple-negative (TN) tumours are the predominant breast cancer subtype in BRCA1 mutation carriers. Recently, it was proposed that all individuals below 50 years of age with TN breast cancer should be offered BRCA testing. We have evaluated the BRCA1 mutation frequency and the implications for clinical practice of undertaking genetic testing in women with TN breast cancer. We undertook BRCA1 mutation analysis in 308 individuals with TN breast cancer, 159 individuals from unselected series of breast cancer and 149 individuals from series ascertained on the basis of young age and/or family history. BRCA1 mutations were present in 45 out of 308 individuals. Individuals with TN cancer <50 years had >10% likelihood of carrying a BRCA1 mutation in both the unselected (11 out of 58, 19%) and selected (26 out of 111, 23%) series. However, over a third would not have been offered testing using existing criteria. We estimate that testing all individuals with TN breast cancer <50 years would generate an extra 1200 tests annually in England. Women with TN breast cancer diagnosed below 50 years have >10% likelihood of carrying a BRCA1 mutation and are therefore eligible for testing in most centres. However, implementation may place short-ter...Continue Reading

References

Apr 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN American Society of Clinical Oncology
Aug 19, 2007·BMC Cancer·Diana EcclesUNKNOWN POSH steering group
Nov 6, 2007·Clinical Oncology : a Journal of the Royal College of Radiologists·L S Kilburn, UNKNOWN TNT Trial Management Group
Sep 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Deann P AtchleyBanu K Arun
Jun 26, 2009·The New England Journal of Medicine·Peter C FongJohann S de Bono
May 21, 2010·Breast Cancer Research : BCR·Nasim MavaddatAntonis C Antoniou
Aug 25, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Janice S KwonBanu Arun
Nov 3, 2010·Annual Review of Medicine·Katherine L Nathanson, Susan M Domchek
Nov 12, 2010·The New England Journal of Medicine·William D FoulkesJorge S Reis-Filho
Jan 15, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ana M Gonzalez-AnguloFunda Meric-Bernstam
Jun 10, 2011·Journal of Medical Genetics·D G EvansD M Eccles

❮ Previous
Next ❯

Citations

Sep 13, 2013·Hereditary Cancer in Clinical Practice·Natalia BogdanovaThilo Dörk
May 28, 2015·European Journal of Human Genetics : EJHG·Laura PölslerJohannes Zschocke
Oct 26, 2016·British Journal of Cancer·G HouvenaeghelE Lambaudie
Sep 4, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kari HemminkiAkseli Hemminki
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fergus J CouchPeter A Fasching
Apr 23, 2013·Scientific Reports·Jeyanthy EswaranRakesh Kumar
May 27, 2015·Cancers·Andrew McGuireMichael J Kerin
Mar 29, 2014·The British Journal of Surgery·S M PilgrimM D Tischkowitz
Sep 11, 2018·Journal of Global Oncology·Omalkhair AbulkhairEzzeldin Ibrahim
Sep 18, 2017·Familial Cancer·Gabriela E S FelixOlufunmilayo I Olopade
Apr 2, 2019·Cancer·Huma Q RanaBeth A Overmoyer
Aug 21, 2014·European Journal of Human Genetics : EJHG·Alexandra J van den BroekMarjanka K Schmidt
Feb 16, 2015·Breast Cancer Research and Treatment·Michelle W Wong-BrownRodney J Scott
Aug 15, 2013·BMC Medicine·Brian GodmanLars L Gustafsson
Aug 29, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·R AndrésA Tres
Jul 28, 2019·International Journal of Radiation Biology·Flavia Zita FranciesAns Baeyens
Sep 6, 2015·Archives of Gynecology and Obstetrics·Pankaj Kumar, Rupali Aggarwal
May 29, 2020·British Journal of Nursing : BJN·Nicola ScottEmma Wilson
Jul 5, 2013·International Journal of Cancer. Journal International Du Cancer·Michelle W Wong-BrownRodney J Scott
May 10, 2017·Pathology Oncology Research : POR·Hadjer GacebHassen Mahfouf
Apr 13, 2019·Journal of Translational Medicine·Wijden MahfoudhAbdelfateh Zakhama
Jan 1, 2016·Nano-micro Letters·Satvinder Panesar, Suresh Neethirajan
Mar 29, 2013·Cancer Research·Kristen N StevensFergus J Couch

❮ Previous
Next ❯

Clinical Trials Mentioned

ISRCTN97330959

Software Mentioned

BOADICEA

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Janice S KwonBanu K Arun
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Eleanor L CheungMary S Beattie
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti
L DražanO Coufal
© 2022 Meta ULC. All rights reserved